Incyte
INCY
#1191
Rank
A$28.47 B
Marketcap
A$143.08
Share price
0.20%
Change (1 day)
22.53%
Change (1 year)

Incyte (INCY) - Total debt

Total debt on the balance sheet as of December 2025 : A$57.21 Million

According to Incyte's latest financial reports the company's total debt is A$57.21 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Incyte - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-12-31A$60.33 M-13.82%
2024-12-31A$70 M24.57%
2023-12-31A$56.19 M-7.75%
2022-12-31A$60.92 M-1.46%
2021-12-31A$61.82 M0.01%
2020-12-31A$61.81 M-28.14%
2019-12-31A$86.01 M67.72%
2018-12-31A$51.28 M66.82%
2017-12-31A$30.74 M-96.6%
2016-12-31A$0.90 B6.21%
2015-12-31A$0.85 B3.14%
2014-12-31A$0.82 B11.23%
2013-12-31A$0.74 B132.8%
2012-12-31A$0.31 B3.32%
2011-12-31A$0.30 B6.74%
2010-12-31A$0.28 B-41.44%
2009-12-31A$0.49 B-12.15%
2008-12-31A$0.56 B27%
2007-12-31A$0.44 B-6.08%
2006-12-31A$0.47 B0.76%
2005-12-31A$0.46 B-4.54%
2004-12-31A$0.48 B116.83%
2003-12-31A$0.22 B-26.08%
2002-12-31A$0.30 B-13.06%
2001-12-31A$0.35 B4.56%
2000-12-31A$0.33 B110267.92%
1999-12-31A$0.3 M-76.71%
1998-12-31A$1.3 M
1996-12-31A$0.12 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
A$50.08 B 87,438.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$86.15 B 150,469.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$60.17 B 105,074.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$77.28 B 134,976.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.63 B 1,016.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A$0.17 B 201.68%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
A$69.23 M 20.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
A$54.76 M-4.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.29 B 413.74%๐Ÿ‡บ๐Ÿ‡ธ USA